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The aging of Brazilian population is inevitable. Thus, this article reviews the main aspects related to 
the elderly population, taking into account the particularities and problems encountered in the clinical 
laboratory when serving this population group. We start with a brief review of the aging process 
physiology and then discuss the difficulties of pre-analytical (appropriateness of care), analytical (main 
issues for this age group sorted into body system categories) and post-analytical phases.
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resumo
O aumento da população idosa em nosso meio é fato incontestável. Assim, este artigo faz uma revisão dos 
principais aspectos referentes a essa população, sempre considerando as particularidades e os problemas 
observados no atendimento dessa faixa de população no laboratório clínico. Partimos de uma breve 
revisão sobre a fisiologia do envelhecimento para então percorrermos as dificuldades das fases pré-analítica 
(adequação do atendimento), analítica (principais problemas dessa faixa etária, divididos por sistemas 
orgânicos) e pós-analítica.
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Introduction
The aging process, or senescence, used here as a 
synonym, is a topic that is not thoroughly understood. 
Experimental studies using humans are subject to 
restrictions, and the literature offers models based on 
rodents and other organisms, such as the nematode 
Caenorhabditis elegans, the fruit fly Drosophila melanogaster, 
and the yeast Saccharomyces cerevisiae, whose biological 
characteristics, such as a short life span, a broadly sequenced 
genome, and a well-characterized biology, facilitate 
scientific research.
Biological aspects of aging 
There are proposed theories to explain the aging 
process, and here we provide a brief discussion of each 
as well as a description of the expected changes in some 
organs. There are three proposed theories: evolutionary, 
molecular-cellular (cellular senescence), and systemic.
Evolutionary theory 
Evolutionary theory presents several interesting facets, 
such as the low prevalence of death in early adulthood and 
the increasing prevalence in late adulthood. The maturity 
of reproductive function marks the beginning of aging, and 
the earlier the onset of reproductive capacity, the earlier 
the onset of the aging process(22, 24).
Cellular senescence 
Senescence can be expressed in two ways: stress-
induced senescence resulting from molecular events and 
replicative senescence resulting from the loss of telomeres. 
Telomere shortening can be considered a molecular clock 
that signals replicative senescence.
Theories based on molecular and cellular mechanisms 
of aging are related to errors in protein synthesis that 
accumulate throughout life and mutations that arise due 
to exposure to the external environment, especially sub-
lethal doses of radiation, which can induce changes that 
can promote death over the long term. The association 
with errors in DNA replication contributes to increasing the 
likelihood of this outcome(23).
The presence of free radicals predicts that regulatory 
mechanisms of production will become ineffective with 
age, and the accumulation of superoxide causes structural 
damage to cells, causing irreparable damage.
Systemic theory 
The nervous, endocrine and immune systems play an 
important role in controlling the body’s responses to external 
and internal stimuli. A lack of control in the performance of 
these systems will accelerate the aging process(2).
From a neuroendocrine point of view, it is believed that 
aging results from changes that occur in the hypothalamic-
pituitary-adrenal systems, which act as regulators. Changes that 
compromise the function of this axis, such as a low response to 
stimulation, contribute to an accelerated aging process.
Immunological changes are based on two premises: the 
decline of the functional capacity of the immune system 
and increased production of auto-antibodies. Immune 
senescence is thus characterized by reduced resistance 
to infections, the rise of neoplasia, and a reduction of 
the capacity for auto-recognition, which facilitates the 
occurrence of autoimmune diseases.
Cardiovascular system 
Cardiac structural changes are marked by increased 
myocardial thickness, deposition of collagen tissue, and 
increased heart stiffness. Changes in arterial cell and renal 
perfusion are also identified. Coronary heart disease in 
elderly patients is two to three times higher than in patients 
younger than 65(5).
Respiratory system
Conformational changes of the nose and of the costal 
cartilage, costo-vertebral joints, and lungs determine the 
senescence process characteristic of elderly patients. The 
main functional changes in the respiratory tract in elderly are:
• reduction of the chest wall;
• reduction of respiratory muscle strength;
• reduction of vital capacity;
• increased residual volume;
• increased arterial-alveolar oxygen gradient;
• reduction of pulmonary diffusion;
• hypoxia;
• hypercapnia.
Renal system 
Renal blood flow tends to decrease by 50% due to 
a progressively decreasing rate of glomerular filtration. 
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Comorbidities, such as hypertension, diabetes, and previous 
episodes of pyelonephritis, may further influence the effects 
of senescence.
Nutritional and metabolic factors 
There is a decrease in basal metabolism, a redistribution 
of body mass, and change in the digestive system. With 
increasing age, there is an increase in body fat and 
abdominal fat internalization. These phenomena are present 
in both males and females(19).
As a result of obesity, diseases, such as hypertension and 
diabetes, increase in prevalence. An important metabolic 
factor is the occurrence of hyperelectrolytic disturbances, 
such as hyper- or hypo-natremia, which, when associated 
with other comorbidities, are associated with worse 
mortality and morbidity(10).
Laboratory aspects
Pre-analytical factors
When a patient in this age group seeks health services, the 
first concern will be how to welcome the patient. Clinicians 
should also treat the physical facilities involved as a primary 
concern. Each unit should be equipped with devices that 
provide ease and comfort, ensuring the safety of the patients. 
It is important to remember that in this age group, difficulties 
with mobility, hearing, and vision are not uncommon. Clinics 
should be designed with these possible limitations in mind. 
The accessibility of the units should be developed to the 
fullest. Handrails and grips at appropriate heights should 
be available in corridors, collection rooms, and bathrooms. 
Furthermore, toilet bowls should be set at appropriate 
heights, and security handles should be provided. 
The floor should be as uniform as possible, with ample 
provision of ramps and non-slip flooring, avoiding stairs 
and slopes. 
The visual and auditory signals must be clear and 
prominent. Protocols should use large letters for easy 
viewing. 
The process of sample collection should go beyond a 
collector well trained in the collection technique. A tourniquet 
should be applied to the minimum degree necessary, and 
extended use should be avoided. When a tourniquet is 
applied for more than three minutes, it can raise cholesterol 
by 5% and aspartat aminotranferase (AST)  by almost 10%.
It is important to remember that patients of this age 
have to be treated with respect and care but not as children. 
Calmness and patience in this type of care are essential.
The clinical status of these patients may be extremely 
variable. Their state depends not only on the coexistence of 
multiple diseases, but also on aspects related to treatment 
of the patients past medical problems and to how the 
patient has been followed. Therefore, trying to set standards 
in terms of benchmarks and their consequences, such as 
communication or panic levels, becomes a complicated task.
These patients also present with polypharmacy. Drugs 
can interact with each other not only in vivo, but also in vitro. 
Insisting on obtaining information about the current drugs 
being used can solve many problems related to treatment.
Variations in clinical status are also affected by genetic 
factors and aspects of body composition. We know, for 
example, that levels of creatine kinase (CK) enzyme are 
generally higher in populations of African descent because 
individuals in these populations have more muscle mass. By 
contrast, white women have lower muscle mass. Substances 
produced by the muscles (such as CK and creatinine) may 
change(16).
In turn, patients with a higher fat mass have increased 
levels of lipids, transaminases, insulin, glucose, and cortisol.
Menopause can alter the results of tests related to bone 
metabolism, and alkaline phosphatase may vary by up to 25%.
In summary, changes that are frequent in the elderly, 
such as changes in body composition and height loss, 
lead to a new homeostatic balance, which can vary in 
comparison to young adults.
Environmental factors also influence these patients and 
the results of their laboratory tests. Inpatients hospitalized 
for long periods or under inappropriate conditions should 
be evaluated carefully. Patients exposed to constant cold 
may have increased thyroid-stimulating hormone (TSH)  and 
decreased thyroxine hormone (T4). Constant stress can alter 
corticotropin-releasing hormone (CRH) , aldosterone, and 
renin. Additionally, stress can also lower thyroid hormones 
(TSH, triiodothyronine [T3] , and T4).
In immobilized patients (forced postures), the plasma 
volume falls between 5% (on the first day) and 8% (on the 
sixth day). Calcium, urea, and T4 rise, while cortisol and 
metanephrine decrease.
Diet is also an important consideration because these 
patients often have chewing and swallowing problems 
and, therefore, opt for a diet with a higher proportion of 
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carbohydrates and fats. Malnutrition is common, and one 
study showed that up to half of admitted patients have low 
transferrin. The state of hydration must also be taken into 
consideration, and adequate hydration should be ensured.
The circadian rhythm can also change, and sleep 
disturbances are common. Cortisol, aldosterone (which 
depends on movement), TSH, metanephrines, and peptide C 
may be altered in the elderly.
Even healthy habits can affect test results. Exercise, for 
example, leads to higher protein turnover and increases the 
levels of circulating enzymes and stress hormones (cortisol, 
metanephrines, aldosterone, B-type natriuretic peptide 
[BNP]). However, it reduces cholesterol and triglycerides.
Changes in laboratory evaluation of 
physiological systems 
Some changes are more prevalent in this population, and 
we will briefly discuss the clinical-laboratory correlations.
Endocrine changes
The most relevant changes are thyroid and metabolic 
syndromes. Thyroid function remains stable, despite the 
decrease in T3 due to reduced peripheral conversion of T4 
into T3. T4 remains stable because reduced synthesis is offset 
by lower clearance.
There is an increase in the peripheral resistance of these 
hormones, and this resistance explains the fact that the TSH 
remains within the reference range.
Thyroid disorders are also common in this population. 
Hypothyroidism appears in 4% of the population, and it 
is present in subclinical form in 5%(4). Approximately two 
thirds of the population in this age group tested positive 
for anti-thyroid antibodies(12, 14).
Hyperthyroidism also presents with vague symptoms, 
such as cardiac abnormalities (tachycardia, atrial fibrillation, 
angina, congestive heart failure [CHF]), neurological 
abnormalities (weakness, emotional disorders), and 
gastrointestinal abnormalities(15).
Hypothyroidism can also be frustrating to identify 
because the symptoms are not always clear to the doctor. 
It can present as debility, cold intolerance, constipation, 
dry skin, mental confusion, chronic anemia, or other 
autoimmune manifestations. The aspect of confusion can 
be difficult to differentiate from symptoms of dementia. 
Dementia resulting from hypothyroidism has been shown 
to be an important cause of debility. Other serious illnesses 
can present similarly, and therefore, the laboratory plays an 
important role in diagnosis(12).
Metabolic syndrome, which is well known in our 
country, should be considered based on the significant 
increase in its likelihood that is correlated with age(19).
Assessment of renal function 
Kidney function declines with age, falling about 1% per 
year. Renal plasma flow begins to decrease earlier than the 
glomerular filtration rate, which leads to a delay in clearance 
measures for assessing the extent of renal function(6).
Creatinine remains stable because the production and 
excretion rates fall together, i.e., the loss of muscle mass 
(responsible for the production of creatinine) follows the 
reduction in excretion(1). Three factors directly influence the 
plasma concentration of creatinine: muscle mass, age, and 
diet. We know that an overload of animal protein in the diet 
can raise the levels of serum creatinine from 10% to 20%. 
The route of excretion is glomerular filtration (for the 
greater part) and tubular secretion (for the lesser part). During 
renal insufficiency, tubular secretion becomes more significant, 
and purification may be overestimated by 50% to 200%. 
Creatinine purification is not related linearly with serum levels, 
so it is always important to remember that relatively “small” 
changes may indicate large decreases in renal function(7).
Collection of the sample itself can be performed over 
a period of 12 to 24 hours or over shorter periods. Certain 
precautions should be taken, such as ensuring the accuracy 
of timing during collection, starting the test with a proper 
emptying of the bladder, providing adequate hydration, 
and preventing the loss of urine. Ideal hydration should be 
initiated with 20 ml/kg of body weight plus replacement.
In elderly patients, complications related to each of the 
items mentioned may be present, including difficulty for 
understanding the instructions for the collection, incomplete 
bladder emptying (residual urine), water restriction for medical 
reasons, and inability to control and collect urine (patients with 
urinary incontinence, for example).
The formulas most commonly used for estimation 
(Cockcroft-Gault and Modification of Diet in Renal Diseases 
[MDRD]) can be used with good accuracy, but purification 
of less than 60 ml/min is not recommended(8). The use of 
cystatin C may be considered(11), although it is not yet in 
common use in our area.
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Hematological features
Hematological problems are common in the elderly(17). 
Bone marrow also undergoes characteristic changes over 
time. Values that would be considered appropriate in other 
age groups can take on a different clinical significance in the 
elderly(20). Leukocyte counts of approximately 10,000/mm3 
may be normal for a youth, but in the elderly, this count may 
be highly indicative of infection(18).
Anemia is a disease that is more prevalent in the elderly(9). 
Its prevalence increases with age and other comorbidities. 
These include iron deficiency, chronic disease, bleeding, 
and injuries to the spinal cord(3) (myelodysplasia and 
myeloproliferative disorders). A suggested strategy is to 
administer ferritin to differentiate between anemia caused 
by iron deficiency and that caused by chronic disease.
Lymphomas and myelomas are also important 
manifestations in this age group because their clinical 
manifestations are different from those observed in young 
adults(25). Anemia is a disease that is more prevalent in 
the elderly. Its prevalence increases with age and other 
comorbidities. These include deficiency, chronic disease, 
bleeding and injuries to the spinal cord (myelodysplasia 
and myeloproliferative disorders).
Markers of inflammatory activity
Inflammatory diseases are a common problem in older 
people. Thus, the evaluation of markers of these diseases 
involves some care regarding the interpretation of results(13).
The tests are nonspecific, with high sensitivity, low 
specificity, low positive predictive value (PPV) and high 
negative predictive value (NPV). Therefore, negative results 
should be evaluated, and positive results should be carefully 
analyzed.
Common exams in clinical practice, such as antinuclear 
factor and thyroid antibody tests, also deserve attention. 
In an important study, Tan et al. showed that up to 3% of 
the population may have false-positives in high titers(21).
Anti-thyroid antibodies, as well as other auto-antibodies, 
have an elevated incidence with increasing age.
Monitoring of therapeutic drugs
High or low values can be found in this range. Difficulty 
of absorption due to reductions in motility and the 
absorptive surface and differences in tissue distribution, with 
more body fat and less tissue perfusion, are factors involved 
in therapeutic drug levels. Additionally, metabolism is slower 
and excretion is impaired by reduced kidney and/or liver 
function(18, 26).
Conclusion
Increases in the elderly population, especially those 
considered very old (over the age of eighty years), make 
it necessary to study this age group not only from the 
standpoint of institutional policies but also to address 
the various clinical and physiological factors that they are 
subject to. 
It falls to the physician, regardless of specialty, to take 
into account that the diagnosis or treatment of elderly 
patients always depends on careful analysis of the disease 
and the physiological changes associated with age. No 
less important are aspects related to quality of life, such as 
functional changes, which are studied by evaluating the 
normal and instrumental activities of daily living. Finally, 
these patients also often suffer from co-morbidity caused 
by a combination of diseases.
As noted above, the physiological changes caused by 
aging interfere significantly with the function of organs 
and systems, which is reflected in the results obtained in 
laboratory tests. Thus, the correct interpretation of these 
tests depends, more directly than in young adults, on the 
analysis of the clinical, functional, and social characteristics 
of each patient.
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